Table 2.
Protein autoDFs profiling based on own data.
| Protein Profiling | |
|---|---|
| Mesenchymal markers/expression-cells+% | |
| CD73 (NT5E 5′-nucleotidase ecto) | Hi/>95 |
| CD90 (THY1 Thy-1 cell surface antigen) | Hi/>99 |
| CD105 (ENG endoglin) | Hi/>98 |
| Collagen I (COL1A1 collagen type I alpha 1 chain) | Hi/>95 |
| Collagen III (COL3A1 collagen type III alpha 1 chain) | Hi/>95 |
| Elastin (ELN elastin) | Hi/>95 |
| Vimentin (VIM vimentin) | Hi/>98 |
| Prolyl 4-hydroxylase (P4HB prolyl 4-hydroxylase subunit beta) | Hi/>99 |
| Endothelial and hematopoietic markers/expression-cells+% | |
| CD31 (PECAM1 platelet and endothelial cell adhesion molecule 1) | Low/<1 |
| CD34 (CD34 CD34 molecule) | Low/<1 |
| CD45 (PTPRC protein tyrosine phosphatase receptor type C) | Low/<1 |
| Epithelial markers/expression-cells+% | |
| CD324 (CDH1 Cadherin 1, Type 1, E-Cadherin (Epithelial)) | Low/<0.5 |
| pan-Cytokeratin 14,15,16,19 (KRT14, KRT15, KRT16, KRT19) | Low/<0.5 |
| Differentiation markers/expression-cells+% | |
| Aggrecan (ACAN aggrecan)—chondrogenic | Low/<1 |
| Osteocalcin (BGLAP bone gamma-carboxyglutamate protein)—osteogenic | Low/<1 |
| FABP4 (FABP4 fatty acid binding protein 4)—adipogenic | Low/<0.5 |
| a-SMA (ACTA2 actin alpha 2)—smooth muscle | Variable/1–30 |
| a-sk-Actin (ACTA1 Actin Alpha 1)—skeletal muscle | Low/<1.5 |
| sk-Myosin (MYH1 Myosin Heavy Chain 1)—skeletal muscle | Low/<0.5 |
| Myogenin (MYOG myogenin)—myogenic | Low/<0.5 |
| MyoD1 (MYOD1 myogenic differentiation 1)—myogenic | Low/<0.5 |